Digestive enzymes refer to compounds that aid in digestion by assisting with food breakdown. These proteins accelerate the chemical processes that transform food into compounds that can be absorbed by the digestive system. The salivary glands and the cells lining the stomach, pancreas, and small intestine produce (release) them. The main types of digestive enzymes are carbohydrates, protease, lipase, and other enzyme types. Lipase is a protein produced by the pancreas; a small organ located near the stomach that aids in fat digestion. The enzymes originated from animals, fungi, microbial, and plants that are used for indigestion, chronic pancreatitis, irritable bowel syndrome, and other applications. The various distribution channel includes retail stores and online stores. The digestive enzymes market research report is one of a series of new reports from The Business Research Company that provides digestive enzymes market statistics, including digestive enzymes industry global market size, regional shares, competitors with a digestive enzymes market share, detailed digestive enzymes market segments, market trends and opportunities, and any further data you may need to thrive in the digestive enzymes industry. This digestive enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global digestive enzymes market grew from $0.82 billion in 2022 to $0.89 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The digestive enzymes market is expected to grow from $1.32 billion in 2027 at a CAGR of 10.3%. The rising prevalence of the gastrointestinal disorder among different age groups drives the growth of the digestive enzymes market. Gastrointestinal disorders include disorders in the gastrointestinal tract starting from the mouth, oesophagus, stomach, small intestine, large intestine, and anus caused due to lack of digestive enzymes. Gastrointestinal disorders require the digestive enzymes to be taken orally as a dietary supplement or as a drug. The increased rates of gastrointestinal disorders are linked to smoking, diet and genetics, sanitation, increased use of antibiotics, and the changing environmental factors due to industrialization and urbanization. According to the American Gastroenterological Association’s survey published in April 2020 on the worldwide prevalence and burden of functional gastrointestinal disorders, among 73,076 adult respondents, about 40.3% of people met the diagnostic criteria for at least 1 functional gastrointestinal disorder (FGIDs). FGID was more prevalent among women than men. A large-scale multinational study found that more than 40% of the population is having FGIDs across the globe. Therefore, the increase in the prevalence of digestive diseases contributes to the growth of the market. The potential side effects of digestive enzyme supplements and drugs restrain the growth of the digestive enzymes market. Continuous intake of digestive enzymes increases dependency on the digestive enzymes resulting in a weaker digestive system over time. The weakened digestive system leads to digestive distress, gas, nausea, bloating, decreased stomach acid, and allergic reactions accompanied by diarrhea and vomiting. For instance, the digestive enzyme bromelain causes thinning of the blood and increases the risk of excess bleeding. The thinning of the blood is the result of the anti-platelet activity caused by the drug. Thus, the side effects caused by the excess and continuous intake of digestive enzymes negatively impact the growth of the digestive enzyme market. The companies in the digestive enzymes market are investing in developing customized digestive enzymes. These customized digestive enzymes are condition-specific enzymes to support digestion for digestive sensitive patients and may contain multiple enzymes in the same product. The companies involved in manufacturing digestive enzymes are developing customized digestive enzymes to ease the digestion of different types of food. For instance, Sabinsa, a USA-based provider of herbal extracts, cosmeceuticals, minerals, and dietary supplements, formulated DigeZyme. DigeZyme is a multi-enzyme complex comprising five different enzymes, namely, cellulase, lactase, amylase, lipase, and protease. It is widely used by people who have difficulty in digesting carbohydrates, fats, and proteins, respectively. The companies are increasingly investing in developing customized digestive enzymes. In January 2020, Nestlé, a Switzerland-based food and drink processing corporation, entered into an asset purchase agreement with Allergan, an Ireland-based pharmaceutical company that acquires, develops, and markets brand name drugs, to acquire Zenpep for an amount undisclosed. Through the acquisition, Nestle aims to expand its medical nutrition portfolio by including Zenpep products to support food ingestion, digestion, and absorption. Zenpep is a medication for people who cannot digest food properly due to the lack of digestive enzymes. Major players in the digestive enzymes market are Garden of Life, Biotics Research Corporation, Klaire Laboratories, Abbott Nutrition, AbbVie Inc., Allergan PLC., Johnson & Johnson Inc. Amway Corporation, Food State Inc., Matsun Nutrition, Metagenics Inc., Twinlab Corporation, Food State Inc., AST Enzymes, VEMO 99 OOD, Advanced Vital Enzymes Pvt. Ltd., Zeus Biotech Limited, Vox Nutrition Inc., Enzyme Bioscience Pvt. Ltd., Metagenics, XYMOGEN Inc., Douglas Laboratories, Thorne Research, Integrative Therapeutics LLC., Pure Encapsulations, Ortho Molecular Products Inc., Designs for Health Inc., Master Supplements Inc., and Proteozymes. North America was the largest region in the digestive enzymes market in 2022. Middle East is expected to be the largest growing region in the global digestive enzymes market during the forecast period. The regions covered in the global digestive enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the digestive enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The digestive enzymes market consists of sales of amylase, maltase, and lactase. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global digestive enzymes market is segmented - 1) By Enzyme Type: Carbohydrates, Protease, Lipase, Other Enzyme Types 2) By Origin: Animal, Fungi, Microbial, Plant 3) By Application: Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications 4) By Distribution Channel: Retail Stores, Online Stores

Digestive health supplements refer to a nutritional supplement that aids in the breakdown of food and liquids into their chemical constituents—carbohydrates, lipids, proteins, and the like—so that the body may absorb them as nutrients and utilise them for energy, cell growth, and repair, and other functions.       The main products in the digestive health supplements market are prebiotics, probiotics, enzymes, fulvic acid, and other products. Prebiotics refer to a type of carbohydrate, mostly fibers, that humans cannot digest but are digestible by their gut bacteria. The main forms include capsules, tablets, powders, liquids, and other forms. They are sold through various distribution channels such as supermarkets or hypermarkets, convenience stores, specialty stores, pharmacies, e-commerce, and other distribution channels. The digestive health supplements market research report is one of a series of new reports from The Business Research Company that provides digestive health supplements market statistics, including digestive health supplements industry global market size, regional shares, competitors with a digestive health supplements market share, detailed digestive health supplements market segments, market trends and opportunities, and any further data you may need to thrive in the digestive health supplements industry. This digestive health supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global digestive health supplements market size grew from $14.02 billion in 2022 to $15.46 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The digestive health supplements market size is expected to grow to $22.69 billion in 2027 at a CAGR of 10.1%. The rising prevalence of digestive diseases is expected to propel the growth of the digestive health supplement market going forward. A digestive disease is any health problem that affects the digestive tract. These problems can range from mild to severe. Digestive health supplements like probiotics, prebiotics, and enzymes help with digestive problems like diarrhea, constipation, inflammatory bowel disease, irritable bowel disease, urinary tract infection, and other gastrointestinal-related digestive problems. For instance, according to the International Foundation for Gastrointestinal Disorders, irritable bowel syndrome is the most common functional GI disorder, with a prevalence rate of 10–15% globally. Additionally, it is one of the most common conditions that require a visit to the doctor. Thus, the rising prevalence of digestive diseases will increase sales and awareness of digestive health supplements, thereby, driving the growth of the digestive health supplement market. Product innovation is the key trend gaining popularity in the digestive health supplements market. Major companies operating in the market are introducing technological innovations such as new ingredients and exploring innovative administration forms to cater to the needs of various age groups to sustain their position in the market. For instance, in April 2021, Bausch Health Companies Inc., a US-based pharmaceutical company, launched a unique proprietary blend of five probiotic strains ingredients, ENVIVE, an over-the-counter probiotic supplement that is formulated to strengthen and protect the digestive system. In May 2022, Glanbia Nutritionals, an Ireland-based nutrition company, acquired Sterling Technology for an amount of $60 million. Through this acquisition, Glanbia Nutritionals aims to scale and strengthen its bioactive solutions portfolio to cater to the needs of its customers. Sterling Technology is a US-based bioactive solution manufacturing company, which offers product solutions in digestive health, Tegricel, a solution that uses NSAIDs to keep the digestive tract healthy. Major players in the digestive health supplements market are Amway Corp, Bayer AG, Pfizer Inc., NOW Foods, Alimentary Health Limited, Nestle, Nutricia, Lonza, Nature’s Bounty, Garden of Life, Zenwise, OLLY Public Benefit Corporation, BASF SE, Herbalife International, and GlaxoSmithKline PLC North America was the largest region in the digestive health supplements market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digestive health supplements market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the digestive health supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The digestive health supplements market consists of sales of L-glutamine, Slippery elm, Ginger root, and vitamin D. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global digestive health supplements market is segmented - 1) By Product: Prebiotics, Probiotics, Enzymes, Fulvic Acid, Other Product 2) By Form: Capsules, Tablets, Powders, Liquids, Other Form 3) By Distribution Channel: Supermarkets/Hypermarkets, Convenience Store, Specialty Store, Pharmacies, E-Commerce, Other Distribution Channels

Specialty enzymes refer to proteins that have the ability to operate as very selective biocatalysts to speed up reactions and create the required target molecule in medicines. Specialty enzymes are important in a wide range of treatment modalities and applications, most frequently for modification but also to lower viscosity and hence enhance processability and to connect and detach cells, which increases productivity. The main types of specialty enzymes are carbohydrases, proteases, lipases, polymerases & nucleases, oxidases and hydratases, and others. Any of a class of enzymes (such as amylase) that promotes carbohydrate breakdown or synthesis is referred to as a carbohydrase (such as a disaccharide). The different sources include microorganisms, animals, and plants and are used in pharmaceutical, diagnostics, research and biotechnology, food and beverage, animal nutrition, and others. The specialty enzymes market research report is one of a series of new reports from The Business Research Company that provides specialty enzymes market statistics, including specialty enzymes industry global market size, regional shares, competitors with a specialty enzymes market share, detailed specialty enzymes market segments, market trends and opportunities, and any further data you may need to thrive in the specialty enzymes industry. This specialty enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global specialty enzymes market grew from $5.57 billion in 2022 to $5.97 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The specialty enzymes market is expected to grow from $7.8 billion in 2027 at a CAGR of 6.9%. Growing investment in biotechnology research and development is expected to boost market growth during the forecast period. Specialty enzymes are widely used in biotech research and development, particularly in molecular biology. The increasing investment and an increase in the number of companies conducting biotechnology research and development will in turn increase the number of biotech researchers. For instance, in April 2021, according to a report published by the Congressional Budget Office, a US-based government agency that provides budget and economic information, pharmaceutical companies will have invested $83 billion on research and development activities around the world. According to the Assobiotec publication BioInItaly 2020, healthcare is involved in 49% of the over 700 biotech firms headquartered in Italy. As a result of increased investment in biotech R&D, the growing number of biotech research companies is expected to boost the specialty enzymes market. Ethical and societal issues are factors that will slow down the market's growth during the forecast period. The clashing public opinions on these issues will determine the acceptability of new industrial biotechnology products. In 2019, a published article stated that there are five societal and ethical themes concerning industrial biotechnology, namely sustainability, naturalness, risk management, innovation trajectories, and economic justice. Many critics state that the factor affecting economic justice is that the applications of industrial biotechnology lead to the concentration of knowledge and power in the hands of a few companies. Thus, societal and ethical issues are expected to impact market growth. Technological advancements show opportunities for the production of enzyme products more efficiently. Challenges such as complexity in maintaining pH, the operational high temperature of specialty enzymes, and the significant cost of maintenance of specialty enzyme products pave the way for technological advancements. For instance, in February 2020, DuPont Nutrition Biosciences ApS, a Denmark based company specialising in the development, manufacturing, and sale of ingredients for food and beverages, enzymes, and bio-based products, launched the POWERBake enzyme based on its emulsification technology. The enzymes give bakeries and improvement centers a special emulsification solution that satisfies consumer expectations for cleaner labelling while maintaining the flavour and quality of white breads and buns. In May 2021, BRAIN AG, a Germany-based industrial biotechnology company that identifies and develops innovative solutions and products for use in the chemistry, cosmetics, and food industries, paid $ 5.51 million (GBP 3.9 million) for additional shares in Biocatalysts Ltd.The acquisition further strengthens BRAIN’s BioIndustrial segment and widens commercial opportunities with Biocatalyst's portfolio and technology, including access to BRAIN’s unique BioArchive and Biocatalyst’s MetXtra metagenomic library. Biocatalysts Ltd. is a UK-based manufacturer of specialty enzymes that focuses on the use of technology to develop novel specialty enzymes cost-effectively. Major players in the specialty enzymes market are BASF SE, Novozymes A/S, Roche Holding AG, Codexis Inc., Specialty Enzymes & Probiotics, Advanced Enzyme Technologies Ltd., BBI Solutions, E. I. du Pont de Nemours and Company, Sanofi, and Amano Enzyme Inc. North America will be the largest region in the viral specialty enzymes market in 2022. The Middle East is expected to be the fastest growing region in the global specialty enzymes market during the forecast period. The regions covered in the global specialty enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The specialty enzymes market consists of sales of acylases, hydratases, humulin oxidase, and lyases. Values in this market are "factory gate values," that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The countries covered in the specialty enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global specialty enzymes market is segmented - 1) By Type: Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, Oxidase & Hydratases, Other Types 2) By Source: Microorganisms, Animals, Plants 3) By Application: Pharmaceutical, Diagnostics, Research & Biotechnology, Food & Beverage, Animal Nutrition, Other Applications

Digestive health is a system that enables the body to efficiently digest food and absorb nutrients, maintaining overall health. Constipation, heartburn, bloating, indigestion, and other digestive issues are less common in those with sound digestion, as are more severe digestive illnesses. The main types of digestive health products are functional foods and beverages, vitamins and dietary supplements, and other products. The functional foods and beverages offer health benefits beyond their nutritional value. Functional food and beverages are products that have an added physiological benefit above and beyond their naturally occurring benefits. The various ingredient used in digestive health products are probiotics, prebiotics, digestive enzymes, and other ingredients. The digestive health products are distributed through supermarkets/hypermarkets, hospital pharmacies, online pharmacies, and other distribution channels. The digestive health market research report is one of a series of new reports from The Business Research Company that provides digestive health market statistics, including digestive health industry global market size, regional shares, competitors with a digestive health market share, detailed digestive health market segments, market trends and opportunities, and any further data you may need to thrive in the digestive health industry. This digestive health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global digestive health market size grew from $49.3 billion in 2022 to $55.7 billion in 2023 at a compound annual growth rate (CAGR) of 13.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The digestive health market size is expected to grow to $84.45 billion in 2027 at a CAGR of 11.0%. The rising geriatric population is driving the digestive health market. The geriatric population consists of adults 65 years of age and older. The digestive system may not function as swiftly or as efficiently as it once did as people age because numerous biological processes slow down with advancing years. The muscles in the digestive system become stiffer, softer, and less effective over time. Digestive health products aid the body in efficiently digesting food and absorbing nutrients, maintaining overall health. For instance, in June 2020, according to a study by the United Nations, the total number of people age 80 years and above is expected to increase from 143 million in 2019 to over 426 million in 2050. Therefore, the increasing geriatric population is expected to aid the growth of the compression therapy market. New product innovation is a key trend in the digestive health market. Detoxification is gaining popularity, which is being taken as an opportunity by major digestive health companies. A series of procedures known as detoxification is intended to treat acute intoxication and withdrawal. For instance, in August 2022, JP Holistic Nutrition, a UK-based online pet supplement store, launched Urban Retreat RESET. Urban Retreat Reset detox is a beverage for digestion and gut health. Digestive enzymes, probiotics, and prebiotics are all ingredients in this supplement for digestive health. It conatins alkalizing products that enhance wellbeing, sleep, mood regulation, and brain health. In March 2021, PanTheryx, the colostrum-based nutrition and biotechnology company, acquired TruBiotics from Bayer HealthCare LLC for an undisclosed amount. Through this acquisition, PanTheryx will expand its product portfolio in the probiotics and microbiome category. TruBiotics is a probiotic brand of Bayer AG, a German multinational pharmaceutical and biotechnology company, that specialises in nutritional supplements, including probiotics. Major players in the digestive health market are Chr. Hansen Holdings A/S, Yakult Honsha Co. Ltd., Nestle SA, DuPont, PepsiCo Inc., Danone A.S., Cargill Inc., General Mills, Inc., Arla Foods, Inc., Mondelez International Inc., Deerland Probiotics & Enzymes, Inc., Sanofi, BASF SE, Bayer AG and AST Enzymes. North America was the largest region in the digestive health market in 2022. The regions covered in the digestive health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the digestive health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The digestive health market includes revenues earned by entities by food enzymes and microbial-based ingredients. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global digestive health market is segmented - 1) By Product Type: Functional Foods and Beverages, Vitamins and Dietary Supplements, Other Products 2) By Ingredient Type: Probiotics, Prebiotics, Digestive Enzymes, Other Ingredients 3) By Distribution Channel: Supermarkets/Hypermarkets, Hospital Pharmacies, Online Pharmacies, Other Distribution Channels

Functional foods are highly nutritious foods that are associated with many health benefits. The benefits include prevention against nutrition deficiencies, protection against diseases, improved cholesterol levels, lower blood pressure, and promotion of proper growth & development. The main product types are bakery & cereals, dairy products, meat, fish & eggs, soy products, fats & oils, and other product types. A dairy product is milk and any of the foods made from milk, including butter, cheese, ice cream, yogurt, and condensed and dried milk. The ingredients used for functional foods are carotenoids, dietary fibers, fatty acids, minerals, prebiotics, probiotics, vitamins, and other product types. The various applications of these food products are sports nutrition, weight management, immunity, digestive health, clinical nutrition, cardio health, and other product types. The functional food research report is one of a series of new reports from The Business Research Company that provides functional food statistics, including functional food industry global market size, regional shares, competitors with functional food share, detailed functional food segments, market trends and opportunities, and any further data you may need to thrive in the functional food industry. This functional food research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global functional foods market size will grow from $203.64 billion in 2022 to $229.7 billion in 2023 at a compound annual growth rate (CAGR) of 12.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global functional foods market size is expected to grow from $354.96 billion in 2027 at a CAGR of 11.5%. The increasing number of diseases is shifting consumers' focus to healthy eating, which in turn is projected to boost the demand for functional foods. Functional food provides the human body with healthy nutrition, vitamins and minerals, and reduces the risk of diseases. According to the Centre for Disease Control and Prevention, heart disease is a leading cause of death in the USA, and about 6,47,000 Americans die from heart disease every year, which is one out of every four deaths. Therefore, the increasing number of cardiovascular and other diseases across the globe is anticipated to generate higher demand for a healthy diet, which in turn, is likely to propel the revenues of the functional food market over the forecast period. The higher price of functional food products attributed to the inclusion of healthier or natural ingredients is limiting the growth of the functional food market. Functional foods are sold at higher prices and hold larger profit margins than conventional foods. Functional foods are priced 30 to 500% higher than comparable conventional foods. Thus, the higher prices of functional food are to act as a major restraint for the growth of the functional food market over the forthcoming years. Key players dealing in the functional food market are increasingly focusing on new product developments and company expansion to meet the rising demand from consumers. For instance, in January 2022, Fonterra Co-operative Group Limited, New-Zealand-based dairy company, Tillamook Country Creamery Association (TCAA), and Three Mile Canyon Farm, introduced Pro-Optima TM, A-grade functional whey protein concentrate. Pro-Optima TM can be used in cultured products such as yogurt, to enhance the textures to deliver multi-functional benefits. In July 2021, Kerry Group, an Ireland-based food company acquired Biosearch Life for a deal of $ 150 million. Through this acquisition, Kerry Group aims to expand its product portfolio in health ingredients such as probiotics and omega 3s. Biosearch Life is a Spain-based biotechnology company. Major players in the functional food market are, Unilever, BNL Food Group, Dean Foods, The Coca-Cola Company, Arla Foods, Abbott Laboratories, PepsiCo Inc., Kraft Foods Inc., and Nestle. Asia-Pacific was the largest region in the functional food market in 2022. Western Europe was the second-largest region in the global functional foods market. The regions covered in the global functional foods market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the functional food market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The functional food market consists of sales of fatty acids, carotenoids, prebiotics & probiotics, vitamins, dietary fibers, minerals, and other functional foods. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global functional foods market is segmented - 1) By Product Type: Bakery & Cereals, Dairy Products, Meat, Fish & Eggs, Soy Products, Fats & Oils, Other Product Types 2) By Ingredients: Carotenoids, Dietary Fibers, Fatty Acids, Minerals, Prebiotics & Probiotics, Vitamins, Other Ingerdients 3) By Application: Sports Nutrition, Weight Management, Immunity, Digestive Health, Clinical Nutrition, Cardio Health, Other Applications

Weight loss supplements refer to dietary supplements that aid in weight loss by preventing the absorption of fat or carbs, reducing hunger, or accelerating metabolism. However, there is few scientific proof that diet pills are effective. These supplements boost metabolism and thermogenesis while decreasing macronutrient absorption, hunger, body fat, and weight. The main type of weight loss supplements includes liquid, powder, softgels, pills, and other types. A soft gel is a customized capsule that serves as an oral dosage form for medicine. The shells used in soft gels are made up of water, an opacifier, and a plasticizer like glycerin or sorbitol. The ingredients used in weight loss supplements include vitamins & minerals, amino acids, and natural extracts/botanicals. They are used by users age groups ranging from under 18 years, 18 to 40 years, 40 to 50 years, and above 50 years, and they are distributed through offline and online channels. The weight loss supplements market research report is one of a series of new reports from The Business Research Company that provides weight loss supplements market statistics, including weight loss supplements industry global market size, regional shares, competitors with a weight loss supplements market share, detailed weight loss supplements market segments, market trends and opportunities, and any further data you may need to thrive in the weight loss supplements industry. This weight loss supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global weight loss supplements market size grew from $34.5 billion in 2022 to $39.18 billion in 2023 at a compound annual growth rate (CAGR) of 13.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The weight loss supplements market size is expected to grow to $65.16 billion in 2027 at a CAGR of 13.6%. The growing obese population is driving the growth of the weight loss supplements market. Obesity refers to the abnormal or excessive accumulation of fat, which might impair the health of individuals. In recent years, obesity has become a public health challenge across the globe, with a substantial contribution to global mortality and morbidity. The growing obese population is predicted to boost demand for weight loss supplements as these are widely adopted by individuals as healthy options to reduce weight. For instance, according to the World Health Organization (WHO), over 1 billion people globally are obese currently (2022), of that, 650 million are adults, 340 million are adolescents and 39 million are children. By 2025, around 167 million people; adults and children will become less healthy as they are overweight or obese. Thus, the growing obese population is expected to boost demand for weight loss supplements during the forecast period. The development of new production technologies and innovative products is a key trend gaining popularity in the weight loss supplements market. Major companies operating in the weight loss supplements market are focused on developing innovative weight loss supplements to meet fast-growing end customer demands and strengthen their position in the market. For instance, Nature's Formulas, a US-based supplement company has developed BioFit, an innovative, industry-leading probiotic weight loss supplement manufactured from natural ingredients. This product includes natural ingredients and 800 milligrams of microbes that can survive harsh stomach acids to quickly improve digestion, increase energy, and speed up fat loss with no side effects. The company has developed this product to target and help customers lose body weight without following strict diet plans, exercise, or weight-reducing surgeries. In January 2022, Solace Nutrition, a US-based medical nutrition company acquired the assets of R-Kane Nutritionals for an undisclosed amount. This acquisition of assets helps Solace Nutrition to create synergy between both brands and enhance its growth while providing a presence in an adjacent nutrition market. R-Kane Nutritionals is a US-based company that specializes in high protein meal replacement products for weight management. Major players in the weight loss supplements market are Glanbia PLC, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Abbott, Kellogg Company, Nestle, Kraft Heinz Company, Amway Corp, Ajinomoto Co Inc., Nutratech Ltd., Shaklee Corporation, Transparent Labs, Ultimate Life Ltd., and Vitaco. Asia-Pacific was the largest region in the weight loss supplements market in 2022, and it is also expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the weight loss supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The weight loss supplements market consists of sales of chromium picolinate, glucomannan, and conjugated linoleic acid (CLA). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global weight loss supplements market is segmented - 1) By Type: Liquid, Powder, Softgels, Pills, Other Types 2) By Ingredents: Vitamins & Minerals, Amino Acids, Natural Extracts/Botanicals 3) By Distribution: Offline Channel, Online Channel 4) By End User: Under 18 years, 18 to 40 years, 40 to 50 years, Above 50 years

Protein supplements refer to a nutritional supplement that contains protein and is intended to supplement the diet. A protein supplement helps in building muscle, repairing tissue, and producing enzymes and hormones. It also aids in weight loss and assists in toning of muscles for athletes. The main types of protein supplements include protein powder, protein bars, and ready-to-drink products. Protein powder refers to powdered forms of protein that are derived from plants (soybeans, peas, rice, potatoes, or hemp), eggs, or milk (casein or whey protein). Other components, such as extra sugar, artificial flavors, thickeners, vitamins, and minerals, are added to enhance the flavor and functionality of the powder. Based on raw material, the protein supplements are differentiated by casein protein supplements, whey protein supplements, egg protein supplements, MPC protein supplements, and soy protein supplements. The animal-derived and plant-derived protein supplements are sold through supermarkets, hypermarkets, online stores, and drug stores. The protein supplements market research report is one of a series of new reports from The Business Research Company that provides protein supplements market statistics, including protein supplements industry global market size, regional shares, competitors with a protein supplements market share, detailed protein supplements market segments, market trends and opportunities, and any further data you may need to thrive in the protein supplements industry. This protein supplements market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global protein supplements market size grew from $18.75 billion in 2022 to $20.62 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The protein supplements market size is expected to grow to $29.51 billion in 2027 at a CAGR of 9.4%. The rise in customer preference for food supplements is driving the protein supplements market. Food Supplements are intended to make up for dietary deficiencies among individuals through their regular diet. The desire to lead active and healthy lifestyles has increased participation in sports and fitness activities, driving the demand for food supplements, especially protein supplements. According to the Council for Responsible Nutrition survey 2020, a US-based trade association for ingredient suppliers and manufacturers in the dietary supplement industry, approximately 43% of supplement users have altered their supplement regimens after the pandemic, whereas 91% of these users report an increase in supplement intake, including the addition of new supplements to an existing routine (46%), the taking of the same supplements more frequently (25%), or the increasing of doses (22%). Thus, an increase in customer preference for food supplements is expected to boost the demand for protein supplements during the forecast period. Strategic partnership is a key trend gaining popularity in the protein supplements market. The companies operating in the protein supplement sector are focusing on entering into strategic partnerships to expand their market reach and leverage each other's resources in new product development & marketing activities. In October 2021, a New Jersey-based company that creates collagen supplements entered into a partnership with Entenmann's, owed by Bimbo Bakeries USA. The partnership aims to create a new collagen protein powder with Entenmann's chocolate chip cookies as inspiration. Entenmann is a US-based company that manufactures and delivers baked goods. In February 2022, Nestle Health Sciences, a Switzerland-based provider of nutrition solutions, diagnostics devices, and drugs for specific target areas acquired a majority stake in Orgain, for an undisclosed amount. Through this, Nestle is focused on expanding its product portfolio in the plant-based protein supplement sector and enhancing its business presence in the fast-growing plant-based product sector across the globe. Orgain is a California-based provider of plant-based nutritional products. Major players in the protein supplements market are GlaxoSmithKline (GSK), Glanbia PLC, ABBOTT LABORATORIES (ABBOTT), Amway Corporation, Herbalife International of America, Inc., PepsiCo, AMCO Proteins, QuestNutrition, GNC Holdings, Maker Nutrition LLC, SUPPLEFORM, Vitaco Health Limited, Garden of Life, Melaleuca Inc., Atlantic Multipower UK Limited, International Dehydrated Foods, Inc., Scitec Nutrition, and BRF. North America was the largest region in the protein supplements market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein supplements market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the protein supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The protein supplements market consists of sales of soybean meal, essential amino acid, protein intake, proteins, amino acids, whey protein. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global protein supplements market is segmented - 1) By Type: Protein Powder, Protein Bar, Ready to Drink 2) By Source: Plant-based, Animal-based 3) By Raw Material: Casein Protein Supplements, Whey Protein Supplements, Egg Protein Supplements, MPC Protein Supplements, Soy Protein Supplements 4) By Distribution Channel: Supermarkets & Hypermarkets, Online Stores, Drug Stores

Diagnostic enzymes refer to the enzymes that are employed directly or as part of an assay system to determine the presence or absence of a variety of compounds, and they are used to detect, diagnose, or predict the development of disease conditions. These enzymes are used in diagnosis because of their substrate selectivity and quantified activity when other proteins are present. The main types of products in diagnostic enzymes are carbohydrates, polymerases, nucleases, proteases, and others. Any of a class of enzymes (such as amylase) that promotes carbohydrate breakdown or synthesis is referred to as a carbohydrase (such as a disaccharide). The different sources include animals, microorganisms, and plants and are used in biocatalysts, diagnostics, pharmaceuticals, research, and biotechnology. The diagnostic enzymes market research report is one of a series of new reports from The Business Research Company that provides diagnostic enzymes market statistics, including global market size, regional shares, competitors with a diagnostic enzymes market share, detailed diagnostic enzymes market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic enzymes industry. This diagnostic enzymes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global diagnostic enzymes market grew from $3.8 billion in 2022 to $4.02 billion in 2023 at a compound annual growth rate (CAGR) of 5.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The diagnostic enzymes market is expected to grow from $5.1 billion in 2027 at a CAGR of 6.1%. The rise in the geriatric population, which increases the patient pool for the diagnosis of chronic diseases, contributed to the growth of the diagnostic enzymes market. The proportion of people above the age of 65 increased globally, and age-related chronic ailments also increased. For example, the percentage of seniors is expected to grow from 28% in 2019 to 38% by 2050 in Japan. The increase in the ageing population has increased the patient pool of many chronic diseases such as rheumatoid arthritis, hypertension, diabetes, and cancer. People suffering from these diseases are expected to be more vulnerable to chronic diseases, thus significantly influencing market growth during this period. According to the World Population Ageing report, there were 727 million people over the age of 65 in 2020, accounting for 9.3% of the global population, and this figure is expected to rise to around 16.0% by 2050.According to the World Health Organization report for 2021, approximately 10 million cancer-related deaths occurred in 2020. Thus, the rise in the geriatric population increases the number of patients for the diagnosis of chronic diseases, which, in turn, drives the diagnostic enzymes market. The high sensitivity of enzymes to temperature and pH levels is expected to limit the diagnostic enzymes market. Enzymes need to be stored at optimum temperatures and are generally stored at -20 degrees Celsius. According to the Worthington Biochemical Corporation, variations in the reaction by one or two degrees in temperature may have a change of 10 to 20% in the result. In enzymatic reactions, this is complicated as enzymes are adversely affected by high temperatures, and are expected to be deactivated at even moderate temperatures. Enzymes are affected by changes in pH, as pH is also a factor in the stability of the enzymes. The changes in temperature and pH levels may decrease the efficiency of the diagnostic enzymes, which, in turn, hampers the growth of the diagnostic enzymes market. The use of machine learning and artificial intelligence is gradually gaining popularity in the enzyme diagnostic market. Artificial intelligence (AI) is the simulation of human intelligence in machines and is programmed to display their natural intelligence. Machine learning is a part of AI. Machine learning and AI help companies in the enzyme diagnostic market to conduct a detailed analysis of all relevant data, provide insights into the function of enzymes, and allow physicians to understand the key determinants of the relationship between protein structure, function, and evolution, in terms of the catalysis of the reaction steps of an enzyme. For instance, companies such as BioMarker have invested in AI and machine learning for enzyme diagnostics. In June 2020, Codexis, Inc., a US-based protein engineering company and developer of high-performance enzymes, and Alphazyme LLC., a US-based company in the development and manufacture of nucleic acid metabolising enzymes, announced a co-marketing enzyme supply collaboration agreement for the production and co-marketing of enzymes for life science applications, including diagnostics. This collaboration is expected to leverage the experience and industry knowledge of Alphazyme to accelerate the market introduction of Codexis’ portfolio of high-performing life science and diagnostic enzymes while providing Alphazyme with exclusive manufacturing and co-marketing rights to CodeEvolver-improved enzymes. This partnership will allow both companies to jointly promote and sell these enzymes to innovators in life science and diagnostic markets. Major players in the diagnostic enzymes market are Genzyme, Roche, Codexis, Aldevron, Kaneka Eurogentec, Vigene Biosciences, Amano Enzymes, Advanced Enzymes Technologies, Thermo Fisher Scientific, and EKF Diagnostic. North America was the largest region in the enzymes market in 2022. The Middle East is expected to be the fastest-growing region in the global diagnostic enzyme market during the forecast period. The regions covered in the global diagnostic enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the diagnostic enzymes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The diagnostic enzymes market consists of sales of acid phosphatase, alanine aminotransferase, cholinesterase, and aspartate aminotransferase. Values in this market are "factory gate values," that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global diagnostic enzyme market is segmented - 1) By Product Type: Carbohydrases, Polymerases And Nucleases, Protease, and Other Product Types 2) By Source: Animals, Microorganisms, and Plants 3) By Application: Biocatalysts, Diagnostics, Pharmaceuticals, Research, and Biotechnology